China CAS:145-13-1 Manufacturer

Our eternal pursuits are the attitude of "regard the market, regard the custom, regard the science" along with the theory of "quality the basic, have confidence in the first and administration the advanced" for CAS:145-13-1, With the development of society and economy, our company will hold a tenet of "Focus on trust, quality the first", moreover, we assume to produce a wonderful foreseeable future with every customer.
CAS:145-13-1, Customer's satisfaction is always our quest, creating value for customers is always our duty, a long term mutual-beneficial business relationship is what we've been doing for. We are an absolutely reliable partner for yourself in China. Of course, other services, like consulting, can be offered too.

Hot Products

  • Dutasteride

    Dutasteride

    Dutasteride has EP, USP, CP, IP, JP specification. CEP and FDA available.

    CAS:164656-23-9

  • Medroxyprogesterone Acetate

    Medroxyprogesterone Acetate

    Medroxyprogesterone Acetate has USP、EP、 IP、JP and KP. DMF, GMP is available.

    CAS:71-58-9

  • Mifepristone Tablets

    Mifepristone Tablets

    Mifepristone Tablets Specifications:10mg*1
    Indications:Emergency Contraceptive
  • Misoprostol Tablets 0.2mg*30

    Misoprostol Tablets 0.2mg*30

    Misoprostol Tablets 0.2mg*30
    Indications:Gastric ulcer
  • 16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate is used to observe interaction of some steroid drugs with β-cyclodextrin polymer to calculate the relative strengh of interaction between the hydrophobicity parameters of the drugs and the strenght of the drug-β-​cyclodextrin polymer.

    CAS:86401-80-1

  • 3-Oxo-4-androsten-17β-carboxylic acid

    3-Oxo-4-androsten-17β-carboxylic acid

    3-Oxo-4-androsten-17β-carboxylic acid is an intermediate of Dutasteride.

    CAS:302-97-6

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept